kag: agreed. as i always say, there are two major risks to our investment right now...
1) RECAF doesn't integrate on ARCHITECT
2) ABT's 510k historical sample testing doesn't come out too impressive.
My point was addressing those who are hung up on further licensing deals. ABT is #2 in the world -- we don't need anybody else. We need ABT to move along.
DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.